Hepatitis C virus (HCV) genotype is an important determinant of virological response to antiviral therapies. Currently, there are no data available on the molecular epidemiology and interferon susceptibility of the natural intergenotypic recombinant RF1_2k/1b (RF1) strain.
Authors: Fuat Kurbanov, Yasuhito Tanaka, Elena Chub, Isao Maruyama, Aziza Azlarova, Hiroshi Kamitsukasa, Tomoyoshi Ohno, Stefania Bonetto, Isabelle Moreau, Liam J Fanning, Florence Legrand-Abravanel, Jaques Izopet, Nikolai Naoumov, Takashi Shimada, Sergei Netesov, Masashi Mizokami
Read publication